Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferinject Intravenous Injection 500 mg General Use Surveillance
jRCT2031240252Completed
- Sponsor
- Zeria Pharmaceutical
- Start
- Sep 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ferric carboxymaltose in iron deficiency anemia (IDA), sponsored by Zeria Pharmaceutical. Primary endpoint: Adverse events. Started Sep 2021; status: completed.
02
Drugs
ferric carboxymaltose
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on jRCT2031240252.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031240252.